CordenPharma Small Molecules Platform

CordenPharma Small Molecules Platform

Products
CordenPharma Small Molecules Platform
CordenPharma Small Molecules Platform

Information

Full-Service Partner of Choice from Advanced Intermediates to Drug ProductsIntegrated network of cGMP facilities across Europe and US1,200 m3 of volumetric capacity in 20 L - 28,000 L reactors with various materials of constructionClinical (Phase I-III) and ongoing commercial supply to multiple markets around the world (including US, Europe and Japan)Kilo to Multi-ton production volumes per annumProcess development capabilities (including flow / continuous manufacturing)All sites FDA and EMEA approved facilities with long history of successful regulatory and customer auditsStrong EHS programs in place at sites
Main Categories
Custom ManufacturingIntermediates, Fine and Specialty ChemicalsAPIs (Active Pharmaceutical Ingredients)
Available In
OceaniaNorth America (USA, Canada)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
All Categories
Custom ManufacturingAPI Contract ManufacturingIntermediates, Fine and Specialty ChemicalsAdvanced IntermediatesAPIs (Active Pharmaceutical Ingredients)
Supplied From
FranceItalySwitzerlandUnited States
Corden Pharma InternationalCordenPharma is your One Partner CDMO for the global supply of APIs, Lipid Excipients, Drug Products and Packaging. Through a network of fully-inspected cGMP facilities across Europe and the US organized under six technology platforms - Peptides - Oligonucleotides - Lipids & Carbohydrates - Injectables - Highly Potent & Oncology - Small Molecules - CordenPharma experts translate complex ideas, processes and projects at any stage of development into high-quality products. Discover more about our specialized capabilities in early phase GMP peptide clinical manufacturing targeted for INDs, Lipid NanoParticle (LNP) formulation, LNP Starter kits for design and optimization of LNP formulations, standard lipid catalog, bioavailability enhancement capabilities, oral solid dosage manufacturing, including oral peptide delivery, and expanded capabilities for aseptic and terminal sterile injectable manufacturing.

Log in

See all the content and easy-to-use features by logging in or registering!